Related references
Note: Only part of the references are listed.Detection of intracellular bacterial communities in human urinary tract infection
David A. Rosen et al.
PLOS MEDICINE (2007)
Moxifloxacin prophylaxis in neutropenic patients
H. von Baum et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections
Mark A. Malangoni et al.
ANNALS OF SURGERY (2006)
Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia
C Fogarty et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Bench-to-bedside review: Antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit
MH Kollef
CRITICAL CARE (2005)
Clinical impact and relevance of antibiotic resistance
GL French
ADVANCED DRUG DELIVERY REVIEWS (2005)
Mechanisms of resistance to quinolones
GA Jacoby
CLINICAL INFECTIOUS DISEASES (2005)
Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development
S Simoens et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Antimicrobial activity and a comparison of published pharmacodynamics of gemifloxacin and eight fluoroquinolones against Streptococcus pneumoniae
L Saravolatz et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Moxifloxacin in respiratory tract infections
M Miravitlles
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers
GE Stein et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Which fluoroquinolones are suitable for the treatment of urinary tract infections?
KG Naber
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Share Paper
